NCT04377867View on ClinicalTrials.gov

New Biomarkers for Diagnosis and Follow-up of Patients With LRBA or CTLA4 Deficiencies

UnknownOBSERVATIONAL

Enrollment

30

Participants

Timeline

Start Date

January 15, 2020

Primary Completion Date

July 15, 2022

Study Completion Date

January 15, 2023

Conditions

LRBA DeficiencyCTLA4 Haploinsufficiency

Interventions

DRUG

Abatacept Injection [Orencia]

Patients on abatacept to control disease symptoms

Trial Locations (1)

34903

RECRUITING

Marmara University, Istanbul

Sponsors

Lead Sponsor

Marmara University

All Listed Sponsors

collaborator

The Scientific and Technological Research Council of Turkey

OTHER

lead

Marmara University

OTHER

NCT04377867 - New Biomarkers for Diagnosis and Follow-up of Patients With LRBA or CTLA4 Deficiencies | Biotech Hunter | Biotech Hunter